Logo Comprehensive Cancer Center Niedersachsen
CCC-N > About us > Principal Investigators > Singh

Dr. Shiv Singh

Shiv Singh is a Principal Investigator of SP2 and a member of the Selection Comittee.
 

His research focus lies on epigenetic and transcriptional networks in Pancreatic Ductal Adenocarcinoma (PDAC) heterogeneity and therapy response.

Dr. Singh is a faculty and advisory committee member of the International Max Planck Research School for Genome Science graduate school (IMPRS-GS), PI in the Clinician Scientist Program “Cell Dynamics in pathogenesis and therapy” at the UMG Promotionskolleg for MD students, and a faculty and examination committee member of the University of Göttingen graduate Schools (GGNB, GAUSS, DNB and UMG). In addition, he teaches Cancer Biology to M.Sc. students (DNB program), and Bionmedical Sciences to MD students.

Curriculum Vitae

Year Position
Since 2022 Extension of Max-Eder Group Leader position, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG
Since 2018 Max-Eder Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG
2016-2017 Junior Group Leader, Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, UMG
2014-2016 Postdoctoral Fellow at Barrow Neurological Institute, Phoenix, USA
2011-2014 Postdoctoral Fellow at Philipps-University of Marburg
2006-2010 Dr. rer. physiol (summa cum laude), Philipps-University of Marburg (Supervisor: Prof. Volker Ellenrieder)
2002-2004 Master of Science in Biochemistry, University of Bundelkhand, India